NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Sara Faghihi-Kashani
National Institutes of Health - Bethesda, Maryland / United States
Medical and Health Sciences / Neurology
AD Scientific Index ID: 4487586
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sara Faghihi-Kashani's MOST POPULAR ARTICLES
1-)
Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trialM Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ...Neurotherapeutics 15, 430-438, 2018852018
2-)
An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic …A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ...Neurological Sciences 36, 1121-1126, 2015852015
3-)
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisA Schiffenbauer, M Garg, C Castro, A Pokrovnichka, G Joe, J Shrader, ...Seminars in arthritis and rheumatism 47 (6), 858-864, 2018502018
4-)
Defining anti-synthetase syndrome: a systematic literature reviewG Zanframundo, S Faghihi-Kashani, CA Scirè, F Bonella, TJ Corte, ...Clinical and experimental rheumatology 40 (2), 309, 2022552022
5-)
Baseline high-sensitivity C-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: a population-based studyZ Aryan, A Ghajar, S Faghihi-Kashani, M Afarideh, M Nakhjavani, ...Annals of Nutrition and Metabolism 72 (4), 287-295, 2018492018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept